American Diabetes Association. (2021). Standards of medical care in diabetes—2021. Diabetes Care, 44(Suppl. 1), S1-S232. https://doi.org/10.2337/dc21-Sintroduction
Aronne, L. J., & Thornton-Jones, Z. D. (2019). The use of antipsychotic medications and obesity: Mechanisms and interventions. Journal of Clinical Psychiatry, 80(1), 20-29. https://doi.org/10.4088/JCP.18r12411
Haupt, D. W., & Newcomer, J. W. (2001). Hyperglycemia and antipsychotic medications. Journal of Clinical Psychiatry, 62(27), 15-26.
Lebovitz, H. E. (2020). Insulin resistance: Definition and consequences. In M. J. Brownlee & R. J. Smith (Eds.), Diabetes mellitus: A fundamental and clinical text (pp. 675-689). Lippincott Williams & Wilkins.
Lopert, R. B., & Tonkin, A. L. (2022). Obesity and medication: The causal relationship and its clinical implications. Pharmacotherapy, 42(6), 528-537. https://doi.org/10.1097/01.pharm2022